Clinical Trial Update: A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating MB-001 for moderately to severely active ulcerative colitis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• MB-001

Snippet

Sponsor: Mage Biologics | Conditions: Ulcerative Colitis (UC) | Phase 1, Phase 2 | Status: RECRUITING